Work

Methodological considerations on immunoadsorption versus sham treatment for post-COVID syndrome

Year: 2026

Type: article

Abstract: We read the paper by Marco Stortz et al.1 which is published in the Journal of the Lancet Regional Health - Europe in June 2026 with great interest. The authors aimed to determine whether autoantibody depletion by immunoadsorption is effective to reduce the symptom burden of patients with post-Covid syndrome, with a cross-over study. Although the results of the study are very interesting, however, it seems that several statistical and methodological issues should be considered when interpreting the results.

Source: The Lancet Regional Health - Europe

DOI: 10.1016/j.lanepe.2026.101842

Authors: Kamyar Mansori, Mojtaba Soltani-Kermanshahi

Institutions: Zanjan University of Medical Sciences, Semnan University of Medical Sciences

Language: English

Topic: Long-Term Effects of COVID-19

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,930